𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mathematical modelling of hepatitis C treatment for injecting drug users

✍ Scribed by Natasha K. Martin; Peter Vickerman; Matthew Hickman

Book ID
108196685
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
615 KB
Volume
274
Category
Article
ISSN
0022-5193

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hepatitis C virus among self declared no
Hepatitis C virus among self declared non-injecting sexual partners of injecting drug users
✍ K.M. Roy; D.J. Goldberg; S. Hutchinson; S.O. Cameron; K. Wilson; L. MacDonald πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 63 KB πŸ‘ 1 views

## Abstract While much is known about hepatitis C virus (HCV) among injecting drug users (IDUs), there is scant information about the risk of HCV infection to non‐injecting sexual partners of injecting drug users; it is possible that such individuals may have a greater risk of acquiring HCV than an

Cost-effectiveness of hepatitis C virus
Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations
✍ Natasha K. Martin; Peter Vickerman; Alec Miners; Graham R. Foster; Sharon J. Hut πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 291 KB πŸ‘ 1 views

Injecting drug use is the main risk of hepatitis C virus (HCV) transmission in most developed countries. HCV antiviral treatment (peginterferon-a 1 ribavirin) has been shown to be costeffective for patients with no reinfection risk. We examined the cost-effectiveness of providing antiviral treatment

Molecular analysis of hepatitis C virus
Molecular analysis of hepatitis C virus infection in Bulgarian injecting drug users
✍ Massimo Ciccozzi; Gianni Zehender; Valeria Cento; Alessandra Lo Presti; Pavel Te πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 247 KB πŸ‘ 1 views

## Abstract Intravenous drug users constitute a group at risk for hepatitis C virus (HCV) infection. Today, no data are available on the molecular epidemiology of HCV in Bulgaria despite the fact that in recent years the incidence of acute hepatitis C infection among Bulgarian intravenous drug user